Literature DB >> 19855056

Mitochondrial-derived hydrogen peroxide inhibits relaxation of bovine coronary arterial smooth muscle to hypoxia through stimulation of ERK MAP kinase.

Qun Gao1, Xiangmin Zhao, Mansoor Ahmad, Michael S Wolin.   

Abstract

Mitochondrial reactive oxygen species (ROS) are potentially important in vascular oxygen-sensing mechanisms because hypoxia appears to be a stimulus for mitochondrial ROS generation; however, scavenging of endogenous ROS does not alter relaxation of endothelium-denuded bovine coronary arteries (BCA) to hypoxia. The purpose of this study was to investigate the influence of increasing mitochondrial ROS on the relaxation of BCA to hypoxia. Increasing mitochondrial superoxide with inhibitors of electron transport (10 microM rotenone and antimycin) and by opening mitochondrial ATP-dependent K+ channels with 100 microM diazoxide were observed in this study to attenuate relaxation of BCA precontracted with 30 mM KCl to hypoxia by 68-76% and 38%, respectively. This effect of rotenone is not prevented by inhibiting NADPH oxidase (Nox) activation or scavenging superoxide with Peg-SOD; however, it is reversed 85% and 26% by increasing the consumption of intracellular peroxide by 0.1 mM ebselen and 32.5 U/ml Peg-catalase. Because inhibition of extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase (10 microM PD-98059), but not src kinase or rho kinase, also reverses the effects of rotenone by 69%, the peroxide-elicited force-enhancing effects of ERK appear to be attenuating the response to hypoxia. Rotenone increased the phosphorylation of ERK (by 163%). Activation of ERK in BCA with 0.1 mM peroxide or endogenous peroxide generated by stimulating Nox2 with a stretch treatment or contraction with 100 nM U-46619 also attenuated relaxation to hypoxia. Thus coronary arterial relaxation to hypoxia may be attenuated by pathophysiological conditions associated with increased peroxide generation by mitochondria or other sources that stimulate ERK.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19855056      PMCID: PMC2793133          DOI: 10.1152/ajpheart.00817.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  29 in total

1.  Effects of hypoxia on relationships between cytosolic and mitochondrial NAD(P)H redox and superoxide generation in coronary arterial smooth muscle.

Authors:  Qun Gao; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

2.  Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels.

Authors:  Hiroto Miura; Ruth E Wachtel; Fausto R Loberiza; Takashi Saito; Mamoru Miura; Alfred C Nicolosi; David D Gutterman
Journal:  Circ Res       Date:  2003-02-07       Impact factor: 17.367

3.  Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries.

Authors:  Sachin A Gupte; Muhammad Arshad; Steven Viola; Pawel M Kaminski; Zoltan Ungvari; Golam Rabbani; Akos Koller; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08-21       Impact factor: 4.733

Review 4.  Hypoxic vasorelaxation: Ca2+-dependent and Ca2+-independent mechanisms.

Authors:  George D Thorne; Yukisato Ishida; Richard J Paul
Journal:  Cell Calcium       Date:  2004 Sep-Oct       Impact factor: 6.817

5.  Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta.

Authors:  Liming Jin; Zhekang Ying; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-10       Impact factor: 4.733

Review 6.  Matching coronary blood flow to myocardial oxygen consumption.

Authors:  Johnathan D Tune; Mark W Gorman; Eric O Feigl
Journal:  J Appl Physiol (1985)       Date:  2004-07

7.  Diversity in mitochondrial function explains differences in vascular oxygen sensing.

Authors:  Evangelos D Michelakis; Vaclav Hampl; Ali Nsair; XiCheng Wu; Gwyneth Harry; Al Haromy; Rachita Gurtu; Stephen L Archer
Journal:  Circ Res       Date:  2002-06-28       Impact factor: 17.367

8.  Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade.

Authors:  Richard A Oeckler; Pawel M Kaminski; Michael S Wolin
Journal:  Circ Res       Date:  2003-01-10       Impact factor: 17.367

9.  Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4).

Authors:  Zsolt Bagi; Erika Toth; Akos Koller; Gabor Kaley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03-25       Impact factor: 4.733

10.  Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction.

Authors:  Sachin A Gupte; Pawel M Kaminski; Shimran George; Lioubov Kouznestova; Susan C Olson; Rajamma Mathew; Thomas H Hintze; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-23       Impact factor: 4.733

View more
  16 in total

1.  Mitochondrial monoamine oxidase-A-mediated hydrogen peroxide generation enhances 5-hydroxytryptamine-induced contraction of rat basilar artery.

Authors:  Christina Chui Wa Poon; Sai Wang Seto; Alice Lai Shan Au; Qian Zhang; Rachel Wai Sum Li; Wayne Yuk Wai Lee; George Pak Heng Leung; Siu Kai Kong; John Hok Keung Yeung; Sai Ming Ngai; Ho Pui Ho; Simon Ming Yuen Lee; Shun Wan Chan; Yiu Wa Kwan
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 2.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 3.  The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics.

Authors:  David M Krzywanski; Douglas R Moellering; Jessica L Fetterman; Kimberly J Dunham-Snary; Melissa J Sammy; Scott W Ballinger
Journal:  Lab Invest       Date:  2011-06-06       Impact factor: 5.662

4.  Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia.

Authors:  Boon Hwa Neo; Sharath Kandhi; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-16       Impact factor: 4.733

5.  Exposure of mice to chronic hypoxia attenuates pulmonary arterial contractile responses to acute hypoxia by increases in extracellular hydrogen peroxide.

Authors:  Dhara Patel; Raed Alhawaj; Michael S Wolin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-11       Impact factor: 3.619

6.  Hypoxic relaxation of penile arteries: involvement of endothelial nitric oxide and modulation by reactive oxygen species.

Authors:  Dolores Prieto; Pawel M Kaminski; Zsolt Bagi; Mansoor Ahmad; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-25       Impact factor: 4.733

Review 7.  Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics.

Authors:  Emanuele Marzetti; Anna Csiszar; Debapriya Dutta; Gauthami Balagopal; Riccardo Calvani; Christiaan Leeuwenburgh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-07       Impact factor: 4.733

Review 8.  Relationships between vascular oxygen sensing mechanisms and hypertensive disease processes.

Authors:  Sachin A Gupte; Michael S Wolin
Journal:  Hypertension       Date:  2012-06-18       Impact factor: 10.190

9.  Roles for Nox4 in the contractile response of bovine pulmonary arteries to hypoxia.

Authors:  Mansoor Ahmad; Melissa R Kelly; Xiangmin Zhao; Sharath Kandhi; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-19       Impact factor: 4.733

Review 10.  Mitochondria and cardiovascular aging.

Authors:  Dao-Fu Dai; Peter S Rabinovitch; Zoltan Ungvari
Journal:  Circ Res       Date:  2012-04-13       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.